Here’s the notice, from Allergy, Asthma, & Clinical Immunology, of a paper titled “Severe contact dermatitis due to camomile: a common complementary remedy with potential sensitization risks:”
This article has been retracted by the authors. Although the patients originally gave consent to publication of their cases and images, they withdrew this consent shortly after publication. The article is no longer available online in order to protect patient confidentiality. The author apologizes for the inconvenience.
We’ve tried to contact Sibel Dogan, the author of the paper, to find out why the patients withdrew their consent, but haven’t heard back. In the meantime, here’s the abstract of the paper, which went online on July 15:
Camomile extracts and compositae mix containing herbal remedies are used for several alternative/complementary therapies for a long time. In fact, camomile has been used traditionally in eastern Anatolia as a pain relieving topical anesthetic agent. Besides becoming a popular herbal remedy, camomile is also known for its potential in inducing chemical burn, irritant and allergic contact dermatitis, conjunctivitis and anaphylaxis. Different clinical apperances of camomile allergy was reviewed with three patients using the same topical camomile remedy in this report.
We’ve seen at one case of retraction for breach of confidentiality, but that was because “details of participants that were not de-identified were sent between study sites.” We haven’t seen a case in which patients withdrew their consent after publication.
Hat tip: Rob Siebers